Reducing plasma Free Fatty Acids by acipimox improves glucose tolerance in high-fat fed mice

Acta Physiologica Scandinavica

Volumn 171, Issue 2, 2001, Pages 161-167

  Ahrén, Bo ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acipimox; Free fatty acid; Glucose intolerance; High fat diet; Insulin resistance; Insulin secretion; Mice

Indexed keywords

ACIPIMOX; ANTILIPEMIC AGENT; FATTY ACID; INSULIN; PYRAZINE DERIVATIVE;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; DRUG EFFECT; FAT INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE;

ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INJECTIONS, INTRAPERITONEAL; INSULIN; MICE; MICE, INBRED C57BL; PYRAZINES;

EID: 0035258482     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201x.2001.00794.x     Document Type: Article

References (39)

1. Ahrén, B. 2000. Autonomic regulation of islet hormone secretion. Implications for health and disease. Diabetologia 43, 393-410.
2. Ahrén, B. & Scheurink, A.J.W. 1998. Marked hyperliptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 139, 461-467.
3. Ahren, B., Simonsson, E., Scheurink, A.J.W., Mulder, H., Myrsén, U. & Sundler, F. 1997. Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46, 97-106.
4. Al-Shurbaji, A., Berglund, L. & Björkhem, I. 1990. The effect of acipimox on triacylglycerol metabolism in rat. Scand J Clin Lab Invest 50, 203-208.
5. Best, J.D., Kahn, S.E., Ader, M., Watanabe, R.M., Ni, T.C. & Bergman, R.N. 1996. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19, 1018-1030.
6. Boden, G., Chen, X., Rosner, J. & Barton, M. 1995. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44, 1239-1242.
7. Carlsson, C., Borg, L. & Welsh, N. 1999. Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140, 3422-3428.
8. Carpentier, A., Mittelman, S., Lamarche, B., Bergman, R., Giacca, A. & Lewis, G. 1999. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 216, E1055-E1066.
9. Crespin, S., Greenough, W. & Steinberg, D. 1969. Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest 48, 1934-1943.
10. DeFronzo, R.A., Bonadonna, R.C. & Ferrannini, E. 1992. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318-368.
11. Felber, J.P., Haesler, E. &Jequier, E. 1993. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36, 1221-1229.
12. Foley, J.E. 1992. Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15, 773-784.
13. Fulcher, G.R., Catalane, C., Walker, M. et al. 1992. A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus. Diabet Med 9, 908-914.
14. Fulcher, G.R., Walker, M., Farrer, M., Johnson, A.S. & Alberti, K.G. 1993. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentrations and whole-body lipid oxidation rate. Metabolism 42, 308-314.
15. Grill, V. & Björklund, A. 2000. Dysfunctional insulin secretion in type 2 diabetes: role of metabolic abnormalities. CMLS Cell Molecul Life Sci 57, 429-440.
16. Kahn, S. 1996. Regulation of beta-cell function in vivo. From health to disease. Diabetes Rev 4, 372-389.
17. Kahn, S.E., Prigeon, R.L., McCulloch, D.K. et al. 1993. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43, 587-592.
18. Kelley, D.E. & Mokan. M., Simoneau, J.A. & Mandarine, L.J. 1993. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92, 91-98.
19. Kumar, S., Durrington, P.N., Bhatnagar, D. & Laing, I. 1994. Suppression of non-esterified fatty acids to treat type A insulin resistance syndrome. Lancet 343, 1073-1074.
20. Larsson, H. & Ahrén, B. 1996. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39, 1099-1107.
21. Larsson, H. & Ahren, B. 2000. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 23, 650-657.
22. Lee, K.U., Lee, H.K., Koh, C.S. & Min, H.K. 1988. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31, 285-290.
23. Lee, K.U., Park, J.Y., Kim, C.H. et al. 1996. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats. Metabolism 45, 1408-1414.
24. Lee, S.K., Opara, E.C., Surwit, R.S., Feinglos, M.N. & Akwari, O.E. 1995. Defective glucose-stimulated insulin release from perifused islets of C57BL/6J mice. Pancreas 11, 206-211.
25. Magnan, C., Collins, S., Berthault, M.F. et al. 1999. Lipid infusion lowers sympathetic nervous activity and leads to increased beta cell responsiveness to glucose. J Clin Invest 102, 413-419.
26. Mason, T., Goh, T., Tchipasvili, V. et al. 1999. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48, 524-530.
27. McGarry, J.D. & Dobbins, R.L. 1999. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42, 128-138.
28. Paolisso, G., Gambardella, A., Amato, L. et al. 1995. Opposite effects of short and long term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38, 1295-1299.
29. Qvigstad, E., Mostad, I., Bjerve, K. & Grill, V. 1999. Acute reduction of fatty acids increases insulin secretion in type 2 diabetes. Diabetologia 42, (Suppl.), A153.
30. Randle, P.J., Garland, P.B., Hales, C.N. & Newsholme, E.A. 1963. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
31. Randle, P.J., Priestman, D., Mistry, S. & Halsall, A. 1994. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 37, (Suppl.), S155-S161.
32. Santomauro, A.T., Boden, G., Silva, M.E. et al. 1999. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes 48, 1836-1841.
33. Shimabukuro, M., Koyama, K., Chen, G. et al. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94, 4637-4641.
34. Shimabukuro, M., Zhou, Y.T., Levi, M. & Unger, R. 1998. Fatty acid-induced apoptosis: a link betwen obesity and diabetes. Proc Natl Acad Sci USA 95, 2498-3202.
35. Surwit, R.S., Kuhn, C.M., Cochrane, C., McCubbin, J.A. & Feinglos, M.N. 1988. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37, 1163-1167.
36. Taskinen, M.R. 1999. Strategies for the management of diabetic dyslipidaemia. Drugs 58 (Suppl. 1), 47-51.
37. Taylor, S.I., Accili, D. & Imai, Y. 1994. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 43, 735-740.
38. Thiebaud, D.D., DeFronzo, D.A., Jacot, E. et al. 1982. Effect of long-chain triglyceride infusion on glucose metabolism in man. Metabolism 31, 1128-1136.
39. Zhou, Y.P. & Grin, V. 1995. Palmitate-induced B-cell insensitivity to glucose is coupled to decreased puryvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes 44, 394-399.